The Wilson Therapeutics brand, founded in 2012 (Sweden), from 584 sister brands and 17477 competing brands. Wilson Therapeutics is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. Wilson Therapeutics belongs to the Drug Manufacturers business sector.

Wilson Therapeutics is a brand of ASTRAZENECA (AZN/L) Share price

Date created : 2012 Business sector Drug Manufacturers

Share price and profitability of the share ASTRAZENECA (Wilson Therapeutics)

Buy ASTRAZENECA share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested GBX 10,920.00

Portfolio valuation
ASTRAZENECA (Wilson Therapeutics) over 5 years* GBX 20,200.98

Stock market history ASTRAZENECA (Wilson Therapeutics)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ASTRAZENECA

Icosavax
Icosavax
Ardea Biosciences
Ardea Biosciences
ZS Pharma
ZS Pharma
Acerta Pharma
Acerta Pharma
Taligen Therapeutics
Taligen Therapeutics
Synageva BioPharma
Synageva BioPharma
See more brands of ASTRAZENECA

Rival brands
Wilson Therapeutics

POINT BIOPHARMA
POINT BIOPHARMA
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
ZARBEE'S
ZARBEE'S
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS